On July 23, ImmunityBio, Inc. fell 5.02% in regular trading, trading at $7.675/share, with Turnover of $26.397 million.
Within the Biotechnology sector where ImmunityBio, Inc. belongs, among individual stocks, Lakewood-Amedex Biotherapeutics up 86.02%, Arrowhead Pharmaceuticals up 21.01%, Gilead Sciences up 0.73%, AbbVie down 0.09%, Ionis Pharmaceuticals down 0.71%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)